Aprea Therapeutics Statistics
Total Valuation
APRE has a market cap or net worth of $8.50 million. The enterprise value is -$8.03 million.
Important Dates
The next estimated earnings date is Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
APRE has 5.83 million shares outstanding. The number of shares has increased by 36.17% in one year.
| Current Share Class | 5.83M |
| Shares Outstanding | 5.83M |
| Shares Change (YoY) | +36.17% |
| Shares Change (QoQ) | +1.49% |
| Owned by Insiders (%) | 11.16% |
| Owned by Institutions (%) | 21.91% |
| Float | 4.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 10.41 |
| Forward PS | n/a |
| PB Ratio | 0.63 |
| P/TBV Ratio | 0.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.34
| Current Ratio | 5.34 |
| Quick Ratio | 5.22 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -67.54% and return on invested capital (ROIC) is -45.10%.
| Return on Equity (ROE) | -67.54% |
| Return on Assets (ROA) | -39.12% |
| Return on Invested Capital (ROIC) | -45.10% |
| Return on Capital Employed (ROCE) | -104.63% |
| Revenue Per Employee | $105,127 |
| Profits Per Employee | -$1.73M |
| Employee Count | 8 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.83% in the last 52 weeks. The beta is 1.58, so APRE's price volatility has been higher than the market average.
| Beta (5Y) | 1.58 |
| 52-Week Price Change | -49.83% |
| 50-Day Moving Average | 1.63 |
| 200-Day Moving Average | 2.24 |
| Relative Strength Index (RSI) | 41.77 |
| Average Volume (20 Days) | 35,928 |
Short Selling Information
The latest short interest is 85,074, so 1.46% of the outstanding shares have been sold short.
| Short Interest | 85,074 |
| Short Previous Month | 84,496 |
| Short % of Shares Out | 1.46% |
| Short % of Float | 1.84% |
| Short Ratio (days to cover) | 2.42 |
Income Statement
In the last 12 months, APRE had revenue of $841,012 and -$13.85 million in losses. Loss per share was -$2.31.
| Revenue | 841,012 |
| Gross Profit | -8.76M |
| Operating Income | -14.80M |
| Pretax Income | -13.85M |
| Net Income | -13.85M |
| EBITDA | -14.77M |
| EBIT | -14.80M |
| Loss Per Share | -$2.31 |
Full Income StatementBalance Sheet
The company has $16.53 million in cash and n/a in debt, giving a net cash position of $16.53 million or $2.84 per share.
| Cash & Cash Equivalents | 16.53M |
| Total Debt | n/a |
| Net Cash | 16.53M |
| Net Cash Per Share | $2.84 |
| Equity (Book Value) | 14.14M |
| Book Value Per Share | 2.33 |
| Working Capital | 13.76M |
Full Balance SheetCash Flow
| Operating Cash Flow | -12.74M |
| Capital Expenditures | n/a |
| Free Cash Flow | -12.74M |
| FCF Per Share | -$2.19 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -1,759.36% |
| Pretax Margin | -1,646.84% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APRE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -36.17% |
| Shareholder Yield | n/a |
| Earnings Yield | -162.85% |
| FCF Yield | -149.81% |
Analyst Forecast
The average price target for APRE is $20.00, which is 1,288.89% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $20.00 |
| Price Target Difference | 1,288.89% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 139.71% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Feb 13, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
APRE has an Altman Z-Score of -25.34 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -25.34 |
| Piotroski F-Score | 1 |